Our Core Panel of Speakers

BPharm PhD MRPharmS CChem MRSC CSci FTOPRA	Mike Robertson designs our courses and he has created over 50 public conferences for various conference providers and he has written and personally delivered hundreds of lectures for public and professional organisations in Europe and North America He is a Visiting Lecturer at King's College, University of London He is a Quality Assessor on the WHO Prequalification Programme (Geneva – Copenhagen) and he also writes scientific papers on CMC subjects MORE return to ABOUT US page
BSc MSc PhD MRPharmS MTOPRA	Hugh Delargy is a registered pharmacist, international lecturer and scientific author and a Quality Assessor on the WHO Prequalification Programme (Geneva – Copenhagen) He is an experienced pharmaceutical regulatory consultant with both industrial development and regulatory assessment experience of medicines for clinical trial approvals and marketing authorisations in the EU MORE return to ABOUT US page
MA DPhil CChem FRSC Hon MRPharmS	Derek Calam is a Visiting Professor of Pharmaceutical Sciences, University of Strathclyde He is a Member of the WHO Expert Panels for both Pharmaceuticals and Biologicals and Chairman of the WHO Committee responsible for allocating names to names to medical substances on a global basis and he is a UK-nominated Expert at the European Medicines Evaluation Agency (EMEA) in London MORE return to ABOUT US page
BPharm PhD DSc AKC FRPharmS CChem FRSC	Graham Buckton is Professor of Pharmaceutics at the School of Pharmacy University of London and is Chief Executive Officer of Pharmaterials Limited He is a Member of the Expert Advisory Group (EAG) on Pharmacy and Standards that advises the Commission on Human Medicines, a Member of the British Pharmacopoeia Commission (BPC), a Member of the BPC EAG on Pharmacy and Chairman of the BPC Working Party on Excipients MORE return to ABOUT US page
PhD DSc FRPharmS CChem FRSC FRSM	Chris Marriott is Emeritus Professor of Pharmaceutics in the School of Pharmacy, King’s College, University of London He is a Fellow of the Royal Society of Chemistry (1981), a Fellow of the Royal Pharmaceutical Society (1984) and a Fellow of the Royal Society of Medicine (2009), an international lecturer and scientific author of more than 200 original papers focused largely on inhalation and dermal drug delivery systems He is a Member of the Expert Advisory Group (EAG) on Pharmacy and Standards that advises the Commission on Human Medicines He is a consultant to the pharmaceutical industry and holds Directorships at MedPharm Ltd and Remedica Ltd MORE return to ABOUT US page
David Snodin BSc ARCS PhD MChemA MSc (Toxicology) MSc (Applied Statistics) FRSC MTOPRA	David Snodin is Principal, Xiphora Bipharma Consulting. He is a Fellow of the Royal Society of Chemistry, a Member of The Organisation for Professionals in Regulatory Affairs and a Registered Euro Toxicologist He is an experienced international lecturer and author of many scientific papers on Safety Evaluation of Biopharmaceuticals and specialises particularly on carcinogenicity and genotoxicity issues in medicines development MORE return to ABOUT US page
BSc MSc MRPharmS	Paul Fleming is Technical Director of the British Generic Manufacturers Association (BGMA). BGMA represents and promotes the views of the generic medicines industry in UK and has close and regular discussions with MHRA, other parts of the Department of Health and the NHS. At a European level, he is a key Member of the Regulatory Committee of the European Generic Manufacturers Association, EGA. In both these roles, Paul is involved in the development and implementation of new regulatory guidance. Paul has spent 15 years working for the generic sector of the pharmaceutical industry in Europe in a variety of senior board level roles covering drug regulation, pharmacovigilance and formulation development. In the 1990s he spent six years with the MHRA as a Pharmaceutical Assessor and still holds a formal position as an Expert to the British Pharmacopoeia Commission. He is an experienced and accomplished Lecturer.MORE return to ABOUT US page
PhD FTOPRA	Mark Richardson is an independent consultant in drug development regulatory affairs for small molecule, biotech and advanced therapy products for clients in Europe, the US and the Asia-Pacific region. MORE return to ABOUT US page

The core panel may be boosted by additional presenters with clinical, industrial, legal and academic experience. These additional experts from our network are also likely to have interacted closely with or actually worked for the authorities in medicines licensing or in control, inspection and enforcement situations and they will be chosen because of their specialist expertise in the conference subjects

return to ABOUT US page

FULL DETAILS

M. Robertson

H. Delargy

D. Calam

G. Buckton

C. Marriott

D. Snodin

P. Fleming

M. Richardson